The modulation of the tumor microenvironment by obesity-associated molecules, including hormones and pro-inflammatory cytokines (e.g. TNF-α, IL-6) can play a key role in promoting tumor development and progression and, at the same time, in enhancing T-cells function and immune responses to ICIs. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.